According to their respective PK profiles, exenatide BID and lixisenatide can be categorized as short-acting agents (each has a half-life of 35 h) compared with the long-acting agents liraglutide, exenatide LAR, albiglutide, and dulaglutide, which have half-lives ranging from 12 h to several days [16]
Those in the vines mainly consist of terpenes, lipids, and aromatics, while those in the leaves contain terpenes, alkanes, organic acids, alcohols, aldehydes, ketones, and aromatics (70, 71)
10.1038/ncomms9804 54
When the FDA declared a national shortage of semaglutide, a GLP-1 receptor agonist, in March 2022, compounding pharmacies gained legal permission to produce custom versions of Novo Nordisks key ingredient in Ozempic and Wegovy